COLL vs ED
Collegium Pharmaceutical Inc (COLL) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the COLL and ED stock pages for the full models.
Not investment advice.